Skip to main content
HCPCS J1626 · Level II · Part B drug

J1626: granisetron hydrochloride, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1626

Billing unit
100 MCG
Granisetron hcl injection
ASP payment limit
$0.16
October 2026; -19.6% vs July 2026
Practitioner MUE
30
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1626 is the Level II code for Injection, granisetron hydrochloride, 100 mcg, billed per 100 MCG. The Medicare Part B ASP payment limit for October 2026 is $0.16 per billing unit, down 19.6% from July 2026. The practitioner MUE allows up to 30 units per date of service (MAI 3), so a full 30-unit day is $4.80 at the current limit. Under OPPS it carries status indicator N. J1626 is billed in units of 100 MCG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names granisetron: J1627 (Sustol from Heron Therapeutics; extended-release; billed per 0.1 mg); Q0166 (CMS descriptor names "not to exceed a 24 hour dosage regimen"; oral route; billed per 1 mg). The ASP crosswalk maps 5 NDCs to it, sold as Granisetron HCl by Hikma Pharmaceuticals USA Inc., FreseniUS Kabi USA, LLC, Mylan Institutional LLC. No current Billing and Coding Article lists J1626, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1626 at $0.16 per 100 MCG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.199 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1626
QuarterPayment limitPerCoinsurance
October 2026$0.16100 MCG20%
July 2026$0.199100 MCG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 5 NDCs from 3 labelers to J1626. Report the NDC in the claim's drug segment and bill the number of J1626 units that equals the quantity administered divided by 100 MCG; the last column gives units per full package.

NDCs that crosswalk to J1626
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9744-10Granisetron HClHikma Pharmaceuticals USA Inc.1 × 10100
00143-9745-05Granisetron HClHikma Pharmaceuticals USA Inc.4 × 5200
63323-0318-01Granisetron HClFreseniUS Kabi USA, LLC1 × 110
67457-0863-01Granisetron HClMylan Institutional LLC1 × 110
67457-0864-04Granisetron HClMylan Institutional LLC4 × 140

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1626. For practitioners the limit is 30 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1626 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services303 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital303 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1626 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1626 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1626 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1626 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1626 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1626 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1626 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1626 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1626

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1626

What does HCPCS code J1626 describe?

J1626 is defined by CMS as "Injection, granisetron hydrochloride, 100 mcg". Each billing unit represents 100 MCG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1626 a CPT code?

No. J1626 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as granisetron hydrochloride; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1626 reports the drug itself in 100 mcg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1626 in October 2026?

The ASP-based payment limit is $0.16 per 100 MCG, with 20% beneficiary coinsurance. The July 2026 limit was $0.199. Commercial payers use their own fee schedules.

How many units of J1626 can be billed per day?

The practitioner Medically Unlikely Edit is 30 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J1626?

The October 2026 ASP crosswalk lists 5 NDCs from 3 labelers: Granisetron HCl (Hikma Pharmaceuticals USA Inc.); Granisetron HCl (FreseniUS Kabi USA, LLC); Granisetron HCl (Mylan Institutional LLC). For example NDC 00143-9744-10 (package size 1) equals 100 billing units of J1626.

Does J1626 have NCCI bundling edits?

No active practitioner PTP pairs list J1626 as a column-1 or column-2 code in the v323r0 release.

J1626 vs J1627: what is the difference?

Both are HCPCS Level II codes whose descriptor names granisetron. What sets J1627 apart: Sustol from Heron Therapeutics; extended-release; billed per 0.1 mg. J1626 is billed per 100 mcg, limit $0.16, MUE 30; J1627 is billed per 0.1 mg, limit $2.907, MUE 100. Report the code whose descriptor matches the product and setting in the record.

J1626 vs Q0166: what is the difference?

Both are HCPCS Level II codes whose descriptor names granisetron hydrochloride. What sets Q0166 apart: CMS descriptor names "not to exceed a 24 hour dosage regimen"; oral route; billed per 1 mg. J1626 is billed per 100 mcg, limit $0.16, MUE 30; Q0166 is billed per 1 mg, limit $0.774, MUE 0. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.